1. Home
  2. VANI vs MFC Comparison

VANI vs MFC Comparison

Compare VANI & MFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VANI
  • MFC
  • Stock Information
  • Founded
  • VANI 1998
  • MFC 1887
  • Country
  • VANI United States
  • MFC Canada
  • Employees
  • VANI N/A
  • MFC N/A
  • Industry
  • VANI Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • MFC Life Insurance
  • Sector
  • VANI Health Care
  • MFC Finance
  • Exchange
  • VANI Nasdaq
  • MFC Nasdaq
  • Market Cap
  • VANI 68.1M
  • MFC 49.3B
  • IPO Year
  • VANI 2014
  • MFC 1999
  • Fundamental
  • Price
  • VANI $1.26
  • MFC $31.97
  • Analyst Decision
  • VANI Strong Buy
  • MFC Strong Buy
  • Analyst Count
  • VANI 1
  • MFC 2
  • Target Price
  • VANI $4.00
  • MFC $45.50
  • AVG Volume (30 Days)
  • VANI 154.9K
  • MFC 2.2M
  • Earning Date
  • VANI 08-12-2025
  • MFC 08-06-2025
  • Dividend Yield
  • VANI N/A
  • MFC 3.75%
  • EPS Growth
  • VANI N/A
  • MFC 14.95
  • EPS
  • VANI N/A
  • MFC 1.85
  • Revenue
  • VANI N/A
  • MFC $20,887,744,800.00
  • Revenue This Year
  • VANI N/A
  • MFC $35.15
  • Revenue Next Year
  • VANI N/A
  • MFC $5.64
  • P/E Ratio
  • VANI N/A
  • MFC $17.29
  • Revenue Growth
  • VANI N/A
  • MFC 9.27
  • 52 Week Low
  • VANI $0.91
  • MFC $23.30
  • 52 Week High
  • VANI $1.50
  • MFC $33.07
  • Technical
  • Relative Strength Index (RSI)
  • VANI 67.52
  • MFC 56.03
  • Support Level
  • VANI $1.28
  • MFC $31.19
  • Resistance Level
  • VANI $1.33
  • MFC $32.44
  • Average True Range (ATR)
  • VANI 0.07
  • MFC 0.49
  • MACD
  • VANI 0.01
  • MFC 0.04
  • Stochastic Oscillator
  • VANI 79.55
  • MFC 75.74

About VANI Vivani Medical Inc. (DE)

Vivani Medical Inc is a preclinical-stage biopharmaceutical company. The company develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases. It has two reporting segments, the Biopharm Division and the Neuromodulation Division. The Biopharm Division includes activities from NPM and Vivani Medical Australia Pty Ltd, and the Neurostimulation Division includes activities from Cortigent and its subsidiary in Switzerland.

About MFC Manulife Financial Corporation

Manulife Financial provides life insurance, annuities, and asset management products to individuals and group customers in Canada, the United States, and Asia. Its investment management business contributes approximately 20% of its earnings and has around CAD 1.05 trillion in assets under management and administration as of the end of 2023. The US business, which primarily operates under the John Hancock brand, contributes about 27% of earnings and is mainly focused on providing insurance products for estate, business, and income protection. The Asia segment provides insurance products and insurance-based wealth accumulation products in over 11 countries and contributes around 30% of earnings. The Canadian business segment contributes approximately 23% of earnings.

Share on Social Networks: